PRECISION MEDICINE
AND THE FUTURE
OF GENOMICS
PMFG 2024 SUMMIT
PROGRAM
- 08:30 - 09:00
-
See more details
Opening Ceremony
-
See more details
TRACK-1: NEWBORN GENOME SEQUENCING
- 09:00 - 09:10
-
See more details
Genomic Newborn Screening
Track-1 Chair: Nicolas Encina
Executive Director, International Consortium on Newborn Sequencing (ICoNS), USA
- 09:10 - 09:40
-
See more details
The Future of Genomics in Medicine
Keynote Speaker: Dr. Robert Green
Director, Genomes2People Research Program, Harvard Medical School-USA
- 09:40 - 10:00
-
See more details
Qatar’s Vision for Newborn Genome Screening: Shaping the Future of Health from the Very Beginning
Speakers:
Dr. Ammira Akil: Head, Genetic and Metabolic Disorders Clinical Research Program, Sidra Medicine, Qatar
Dr. Tawfeg Ben Omran: Division Chief, Genetic and Genomic Medicine – Sidra Medicine, Qatar
- 10:00 - 10:30
-
See more details
Accelerating Rare Disease Diagnosis
Introduction: Dr. Nicola Withers
Associate Director of Market Development, AMEA, Illumina, Australia.
Plenary Speaker: Dr. Zornita Stark
Lead Clinical Geneticist and Senior Research Fellow, Victorian Clinical Genetics Services (VCGS) Melbourne, Australia
- 10:30 - 11:00
-
See more details
VIP visit to Exhibition and Networking Coffee
AL-Mayassa Foyer and The Spider Exhibition Zone
- 11:00 - 11:30
-
See more details
The Pivotal Role of Rare Disease Industry in Newborn Genome Sequencing
Dr. Amy Ponte
Director, Global Scientific Affairs & Diagnostics, Specialty Care, Rare Diseases, Sanofi, USA
- 11:30 - 12:00
-
See more details
THE VISIONARY PANEL
Genomics for Newborns: Shaping the Future of Medicine through Preventive Genomic Screening
-
See more details
TRACK-2- POPULATION GENOMIC COHORTS
- 12:00 - 12:10
-
See more details
Global Population Cohorts
Introduction By the Track Chair: Dr. Hamdi Mbarek
Director of Research and Partnerships at Qatar Precision Health Institute
- 12:10 - 12:40
-
See more details
Global Standards and Frameworks in Genomics: The Role of GA4GH in Shaping International Data Sharing and Health Research.
Mr. Peter Goodhand
CEO, Global Alliance for Genomics and Health (GA4GH), Canada
- 12:40 - 12:50
-
See more details
Sidra Medicine’s Role in Precision Medicine and Transforming Clinical Practice and Research in Qatar.
Dr. Younes Mokrab
Head of Medical and Population Genomics and Lead of Neurological Disorders Research Program, Sidra Medicine.
- 12:50 - 13:00
-
See more details
HBKU’s Impact on Advancing Precision Health: Innovations and Contributions
Dr. Markus Wenk
Dean, College of Health and Life Sciences, HBKU
- 13:00 - 13:10
-
See more details
Qatar University’s Role in Advancing Precision Health: Research, Innovation, and Clinical Impact
Dr. Medhat Askar
Associate Vice President for Clinical Affairs, College of Medicine, Qatar University, Doha
- 13:10 - 13:20
-
See more details
UDST Contributions to Bioinformatics in Advancing Precision Health.
Dr. Mohammad Asif Khan
Associate Dean, College of Computing and IT University of Doha For Science and Technology, UDST.
- 13:20 - 13:30
-
See more details
Advancing Precision Medicine in Qatar: The Pioneering Role of Weill Cornell Medicine-Qatar
Dr. Khaled Machaca
Associate dean of research, Weill Cornell Medicine Qatar
-
See more details
LUNCH TIME ACTIVITIES & POSTER VIEWING SESSION (NO CME CREDITS)
AL-Mayassa Foyer and The Spider Exhibition Zone
- 13:30 - 14:30
-
See more details
Al-Mayassa Theater The Future Platform Meeting Room 101 Meeting Room 106 Lunch time
industry talk- BGI Mini-Symposium
Lunch time industry
Platform activity- Platform Activity by SomaLogic
- Platform flash talk 1
- Platform flash talk 2
Lunch time
industry workshop- Workshop by Gulf Scientific
Lunch time
industry workshop- MedTech Corporation
-
See more details
TRACK-3- GENETIC DIVERSITY
- 14:30 - 14:40
-
See more details
Introduction By the Track Chair: Dr. Khalid Fakhro
Chief Research Officer, Sidra Medicine, Qatar
- 14:40 - 15:00
-
See more details
Unraveling Structural Genomic Variation: Insights into Human Biology, Evolution, and Disease.
Dr. Charles Lee
Scientific Director and Professor, the Jackson Laboratory for Genomic Medicine, USA
- 15:00 - 15:20
-
See more details
Talk title: TBD
Dr. Said Ismail
Acting President, Qatar Precision Health Institute (QPHI), Qatar
- 15:20 - 15:40
-
See more details
Leveraging Ancestry Algorithms to Enhance Understanding of Underserved Latin American Populations
Dr. Carlos Bustamante
Founder and CEO, Galatea Bio Inc, USA.
- 15:40 - 16:00
-
See more details
Our Future Health Consortium: Building a Diverse Health Database to Enhance Medical Research and Improve Population Health Outcomes
Dr. Raghib Ali
CEO, Chief Investigator and Chief Medical Officer, Our Future Health, UKz
- 16:00 - 16:20
-
See more details
Talk Title: Africa Genome
Speaker: TBA
- 16:20 - 16:40
-
See more details
Talk title: TBD
Dr. Xin Jin
Director, the Institute of Precision Health, Beijing Genomics Institute (BGI)Group, China
- 16:40 - 17:00
-
See more details
Talk title: FinnGen Program
Speaker: TBA
- 17:00 - 17:30
-
See more details
All OF US Research Program
Keynote Speaker: Geoff Ginsburg (TBC)
Chief Medical and Scientific Officer, All of Us Research Program, National Institutes of Health, USA
- 17:30 - 18:00
-
See more details
Panel Discussion
How Can Understanding Genetic Differences Enhance Precision Healthcare Strategies?
Featured by Carlos Bustamante, Charles Lee, Said Ismail, Xin Jin, Geoff Ginsburg (TBC) and hosted by Dr. Khalid Fakhro
-
See more details
Closing Remarks: Ammira Akil and Khalid Fakhro
- 18:30 - 19:30
-
See more details
Exhibitors Recognition Dinner
The Spider Exhibition Area
Recognition speech by the Summit’s Chairs
Recognition Light Dinner
Bus pickup for Speakers to the hotel
-
See more details
TRACK-4: IMPLEMENTATION OF GENOMIC MEDICINE
- 08:30 - 11:00
-
See more details
Implementing Genomics: Bridging Science and Healthcare
Chair: Sonia Davila
Executive Director, Translational Medicine Division, Sidra Medicine, Qatar
- 08:30 - 09:00
-
See more details
Advancing Rapid Genomic Sequencing for Diagnosing and Treating Genetic Diseases in Intensive Care Units
Keynote Speaker: TBC
- 09:00 - 09:20
-
See more details
Ensuring Equity in Genetic Diagnostics: Strategies for Universal Access to Advanced Testing and Personalized Treatments.
Dr. Tan Ee Shien
Head of SingHealth-Duke-NUS Genomic Medicine Centre, Head Genetics Services, KK Women’s and Children’s Hospital, Singapore
- 09:20 - 09:40
-
See more details
TBC
- 09:40 - 10:00
-
See more details
Integrating Genetic Results: Leveraging CLIA-Certified NGS for Rare Disease Discovery and Patient Care
Margaret Harr
Clinical Genetics Counselor, Center for Applied Genomics, Children Hospitall of Philadiliphoa, USA
- 10:00 - 10:20
-
See more details
Talk title: TBD
Dr. Marilyn M. Li
Vice Chief of the Division of Genomic Diagnostics and Director of Cancer Genomic Diagnostics at Children’s Hospital of Philadelphia
- 10:20 - 10:40
-
See more details
Talk title: TBD
Dr. Nancy B. Spinner
Chief of the Division of Genomic Diagnostics at Children’s Hospital of Philadelphia
- 10:40 - 11:00
-
See more details
Group Q&A and Panel Discussion
Future Directions on The Clinical Implementation of Genomic Medicine
Featured by Dr. Tan Ee Shien, Margaret Harr, Dr. Marilyn M. Li, Dr. Nancy B. Spinner and hosted by Dr. Sonia Davila.
- 11:00 - 11:30
-
See more details
Visit to Exhibition and Networking Coffee
AL-Mayassa Foyer and The Spider Exhibition Zone
- 11:30 - 12:45
-
See more details
THE DEBATE
SPONSORED BY DOHA DEBATES
Details TBA
-
See more details
TRACK-5: GLOBAL HEALTH INNOVATIONS
- 12:45 - 13:45
-
See more details
Innovating in Genomics: Journey of a Health Spin-Off – Navigating Regulatory Hurdles, Funding Strategies, and Market Adoption
Chair: TBC
Keynote Speaker: Dr. Gordon Sanghera, CEO and co-founder of Oxford Nanopore Technologies, UKPanelists: TBA
-
See more details
LUNCH TIME ACTIVITIES & POSTER VIEWING SESSION (NO CMED CREDITS)
AL-Mayassa Foyer and The Spider Exhibition Zone
- 13:45 - 14:30
-
See more details
Al-Mayassa Theater The Future Platform Meeting Room 101 Meeting Room 106 Lunch time
industry talkLunch time industry
Platform activity- Platform Activity by Oxford Nanopore Technologies
- Platform flash talk 1
- Platform flash talk 2
Lunch time
industry workshop- Workshop by Illumina
Speaker: Dr. Joel Fellis
Product Management Vice President, Illumina, USA.
Lunch time
industry workshop- Gulf Scientific
Speaker-TBA
-
See more details
TRACK-6: JUNIOR SCIENTISTS CAREER PATH
- 14:30 - 15:30
-
See more details
Evaluating Your Career Choices: Opportunities in Big Pharma vs. Startups and Academia vs. Research Institutes.
Chairs:
Dr. Medhat Askar: Associate Vice President for Clinical Affairs, Qatar Univerity, Qatar .Motivating Speech From An Emerging Young Scientist
Speaker: Dr. Abdulrahman Al-Subaiey, Postdoctoral Fellow, Immunodysregulation Lab, Sidra Medicine, Qatar.
Panelists:- Dr. Daniel Ory, Chief Medical Officer, Arbor Bio-USA
- Dr. Rayaz Malik, Professor & Assistant Dean for Clinical Investigations, WCM, Qatar
- Dr. Essam Abdelalim, Principal Investigator, Sidra Medicine
-
See more details
TRACK-7: TECH TALKS
- 16:00-18:30
-
See more details
Advancing Healthcare in Qatar: Innovations in Diagnostics, Treatment, and Technology Integration.
Chair: TBD
- 16:00 - 16:20
-
See more details
Talk title: TBD
Dr. Ankit Malhotra
Worldwide Genomics Lead, Public Sector, AWS Health, USA
- 16:20 - 16:40
-
See more details
Advancing Facial Diagnostics: Utilizing Novel Machine Learning Models for Accurate Measurement and Personalized Treatment.
Dr. Mitchell Stotland
Vice Chair, Department of Surgery, Division Chief of Plastic and Craniofacial Surgery, Sidra Medicine, Qatar
- 16:40 - 17:00
-
See more details
Harnessing AI Technologies and Expertise to Propel Human Health: Seizing Opportunities for Innovation and Confidence
Dr. Joanne Hackett
Vice President Health System Services and Head of Genomic and Precision Medicine at, IQVIA, UK.
- 17:00 - 17:20
-
See more details
NVIDIA Presentation
Talk title: TBD
Speaker: TBD
- 17:20 - 17:40
-
See more details
Dell Technologies
- 17:40 - 18:00
-
See more details
Unleashing Healthcare Potential: Advancing Decision-Making Through AI-Powered Analysis
Abhi Verma
Chief Technology Officer, SOPHiA GENNETICS, Switzerland
- 18:00 - 18:30
-
See more details
Group Q & A and Panel Discussion
Advancing Healthcare in Qatar: Innovations in Diagnostics, Treatment, and Technology Integration.
Chair: TBD
-
See more details
Closing Remarks: Ammira Akil and Khalid Fakhro
-
See more details
Gala Dinner
-
See more details
TRACK-8: CUSTOM MADE THERAPIES AND CLINICAL TRIALS
- 08:30 - 08:40
-
See more details
Expert Forum on Custom-Made Therapies and Clinical Trials
Chair: TBD
- 08:40 - 09:10
-
See more details
N-OF-1 Therapeutics
Keynote Speaker: TBD
- 09:10 - 09:40
-
See more details
Featured Keynote Speaker Genomically-Informed Clinical Trials
Dr. Hakon Hakonarson
Director of the Center for Applied Genomics (CHOP) and professor of Pediatrics University of Pennsylvania, USA.
- 09:40 - 10:00
-
See more details
Revolutionizing Medicine: The Promise of RNAi Therapeutics
Speaker: Dr. Wan Yue
Deputy Executive Director of the Genome Institute of Singapore, A*STAR, Singapore
- 10:00 - 10:30
-
See more details
Group Q & A or Panel Discussion
- 10:30 - 11:00
-
See more details
Visit to Exhibition and Networking Coffee
AL-Mayassa Foyer and The Spider Exhibition Zone
- 11:00 - 11:30
-
See more details
Featured Keynote Lecture: From Stem Cell and Cellular Therapies for Severe Disease Conditions to Disease Prevention and Reversal to Prolong Healthspan
Chair: Dr. Matthias Von Herrath, Vice President and Senior Medical Officer, Novo Nordisk and University of Miami, USA
Keynote Speaker: Dr. Camillo Recordi
Director, Cell Transplant Center, University of Miami, USA.
-
See more details
TRACK-9: TYPE 1 DIABETES THERAPIES
- 11:30 - 12:00
-
See more details
Chair: Dr. Matthias Von Herrath, Vice President and Senior Medical Officer, Novo Nordisk and University of Miami, USA
Arresting Type 1 Diabetes: Insights and Innovations from Leading Experts and Clinical Trials.
Keynote Address: Dr. Chantal Mathieu
President of European Association for the Study of Diabetes (EASD), Belgium.
- 12:00 - 12:20
-
See more details
Early Detection and Screening Strategies for Type 1 Diabetes
Dr. Emmanuele Bosi
Professor of Endocrinology, Università Vita-Salute San Raffaele; Director, TrialNet Clinical Center, San, Italy.
- 12:20 - 12:40
-
See more details
The Development and Evaluation of Innovative Interventions and Collaborative Testing
Dr. Manuela Battaglia
Managing Director of The INNODIA iVZW, Clinical Trial Platform of Type 1 Diabetes, Italy.
- 12:40 - 13:10
-
See more details
Featured Keynote Highlights: Novel Therapies for Type 1 Diabetes
Chair: Chantal Mathieu, President of European Association for the Study of Diabetes (EASD), Belgium
Keynote: Dr. Matthias Von Herrath
Vice President and Senior Medical Officer, Novo Nordisk and University of Miami, USA
- 13:10 - 13:40
-
See more details
THE PANEL
Preventing Type 1 DiabetesFeatured by Dr. Chantal Mathieu, Dr. Matthias Von Herrath, Dr. Emmanuele Bosi Dr. Manuela Battaglia and hosted by Dr. Camillo Recordi and Dr. Ammira Akil.
-
See more details
LUNCH TIME ACTIVITIES & POSTER VIEWING SESSION (NO CMED CREDITS)
AL-Mayassa Foyer and The Spider Exhibition Zone
- 13:40 - 14:45
-
See more details
Al-Mayassa Theater The Future Platform Meeting Room 101 Meeting Room 106 Lunch time
industry talkLunch time industry
Platform activity- Platform Activity-TBC
- Platform flash talk 5
- Platform flash talk 6
Lunch time
industry workshop- Illumina
Dr. Samih Al Qawlaq
Lunch time
industry workshop- Sedeer Medical Corporation
Speaker-TBA
-
See more details
TRACK-10: DIALOGUE IN GENE THERAPY
-
See more details
Chair: Dr. Hakon Hakonarson
Director of the Center for Applied Genomics (CHOP) and professor of Pediatrics University of Pennsylvania, USA.
- 14:45 - 15:15
-
See more details
Keynote Address
Talk title: TBDKeynote Speaker: Dr. James Wilson
Rose H. Weiss Professor and Director, Orphan Disease Center, University of Pennsylvania, USA.
- 15:15 - 15:40
-
See more details
Ex-Vivo Gene Editing:
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and Transfusion Dependent β-ThalassemiaDr. Haydar Frangoul
Director, Pediatric Stem Cell Transplant Program, Tristar Centennial Children’s Hospital, Nashville, Tennessee, USA.
- 15:40 - 16:00
-
See more details
In-Vivo Gene Editing:
Development of ABO-101, A Novel Gene Editing Therapy for Primary Hyperoxaluria Type 1Dr. Daniel Ory
Chief Medical Officer, Arbor Biotech, Cambridge, MA, USA
- 16:00 - 16:30
-
See more details
Group Q & A and Panel Discussion
Bridging Perspectives in Gene Therapy: Collaborative Insights and Future Directions
Featured by Dr. James Wilson, Dr. Haydar Frangoul, Daniel Ory
- 16:30-17:00
-
See more details
CLOSING KEYNOTE LECTURE
-
See more details
SUMMARY OF THE EVENT, CLOSING REMARKS, AWARDS and SPONSORS RECOGNITION